DocCheck AG

XTRA:AJ91 Rapporto sulle azioni

Cap. di mercato: €43.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

DocCheck Gestione

Gestione criteri di controllo 4/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Frank Antwerpes

Amministratore delegato

€244.7k

Compenso totale

Percentuale dello stipendio del CEO75.5%
Mandato del CEOno data
Proprietà del CEO55.7%
Durata media del management5.1yrs
Durata media del Consiglio di amministrazione25.7yrs

Aggiornamenti recenti sulla gestione

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Recent updates

We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

Apr 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Aug 04
DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

May 20
Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Nov 06
The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

Mar 03
Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Jan 18
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Aug 26
Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

May 02
Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Apr 18
Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Mar 23
Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 04
Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Feb 14
Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Jan 27
Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

Jan 10
Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Dec 22
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 22
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Frank Antwerpes rispetto agli utili di DocCheck?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

€2m

Mar 31 2024n/an/a

€2m

Dec 31 2023€245k€185k

€2m

Sep 30 2023n/an/a

€4m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022€250k€190k

€6m

Sep 30 2022n/an/a

€7m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€9m

Dec 31 2021€250k€190k

€11m

Sep 30 2021n/an/a

€12m

Jun 30 2021n/an/a

€13m

Mar 31 2021n/an/a

€11m

Dec 31 2020€211k€151k

€9m

Sep 30 2020n/an/a

€7m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€4m

Dec 31 2019€245k€185k

€3m

Sep 30 2019n/an/a

€3m

Jun 30 2019n/an/a

€3m

Mar 31 2019n/an/a

€3m

Dec 31 2018€244k€184k

€2m

Sep 30 2018n/an/a

€2m

Jun 30 2018n/an/a

€2m

Mar 31 2018n/an/a

€2m

Dec 31 2017€237k€177k

€2m

Compensazione vs Mercato: La retribuzione totale di Frank ($USD 272.28K ) è inferiore alla media delle aziende di dimensioni simili nel mercato German ($USD 538.74K ).

Compensazione vs guadagni: La retribuzione di Frank è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Frank Antwerpes

no data

Mandato

€244,721

Compensazione

Dr. Frank Nicolas Antwerpes serves as the Chief Executive Officer at DocCheck Guano AG. He served as the Chief Executive Officer of DocCheck Medizinbedarf und Logistik GmbH. Dr. Antwerpes serves as Preside...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Frank Antwerpes
President of the Management Board & CEOno data€244.72k55.71%
€ 24.0m
Philip Stadtmann
CFO & Member of Management Board5.1yrs€232.41kNessun dato
Thilo Kolzer
COO & Member of Management Board5.1yrs€234.81kNessun dato
Jens Knoop
CTO & Member of Management Board5.1yrs€195.80kNessun dato

5.1yrs

Durata media

Gestione esperta: Il team dirigenziale di AJ91 è esperto e expertise (durata media dell'incarico 5 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Joachim Pietzko
Chairman of the Supervisory Board25.7yrs€19.20kNessun dato
Winfried Leimeister
Deputy Chairwoman of the Supervisory Board25.7yrs€9.60kNessun dato
Karin Immenroth
Chief Data & Analytics Officer and Member of Supervisory Board2.3yrs€9.60kNessun dato

25.7yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di AJ91 è composto da personale esperto e esperto (durata media dell'incarico 25.6 anni).